Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

CAH

Cardinal Health Stock Analysis – A Concise Overview

Shares of Health Care sector company Cardinal Health moved 0.6% today, and are now trading at a price of $161.5. The Large-Cap stock's daily volume was 206,097 compared to its average volume of 2,440,646. The S&P 500 index returned a -1.0% performance.

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. The company is based in Dublin and has 47,922 full time employees. Its market capitalization is $38,547,529,728. Cardinal Health currently offers its equity investors a dividend that yields 1.3% per year.

15 analysts are following Cardinal Health and have set target prices ranging from $127.12 to $197.0 per share. On average, they have given the company a rating of buy. At today's prices, CAH is trading -4.44% away from its average analyst target price of $169.01 per share.

Over the last year, CAH's share price has increased by 60.2%, which represents a difference of 48.9% when compared to the S&P 500. The stock's 52 week high is $162.31 per share whereas its 52 week low is $93.17. With average free cash flows of $2.4 Billion that have been growing at an average rate of 6.3% over the last 5 years, Cardinal Health is in a position to continue its strong stock performance trend.

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2024 3,762,000 511,000 3,251,000 37.58
2023 2,844,000 481,000 2,363,000 -15.24
2022 3,175,000 387,000 2,788,000 37.41
2021 2,429,000 400,000 2,029,000 28.01
2020 1,960,000 375,000 1,585,000 -33.79
2019 2,722,000 328,000 2,394,000
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS